• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Affymetrix

Affymetrix

  1. All
  2. 3rd Party
  3. Investing
  1. World $5.8 Billion Fluidigm Patent Portfolio Analysis 2017-2022 - Research and Markets

    World $5.8 Billion Fluidigm Patent Portfolio Analysis 2017-2022 - Research and Markets

  2. Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2021- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment - Research and Markets

    Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2021- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment - Research and Markets

  3. Global Pharmacogenomics Market 2014-2024: Advancement in Technology Pharmacogenomics Engineering to Create In-Vivo Environment - Research and Markets

    Global Pharmacogenomics Market 2014-2024: Advancement in Technology Pharmacogenomics Engineering to Create In-Vivo Environment - Research and Markets

  4. Fund Times: Big Changes at DWS High Income Shop

    Plus, news on Janus long/short fund launch, new Thornburg global fund, and more.

©2017 Morningstar Advisor. All right reserved.